Search Results

  • Marchex Case Is a Prelude to Bigger Shorts to Come

    Published: October 02, 2014

    Although I think there could be more downside to the name, it is prudent to book gains given the ~50% return, which at ~$4 per share, which was better than my original $5.2 price target (notably did not include the Allstate loss). Finally, on the long side I wouldn't want to get involved with Mar...

    Read More »